Picture of Apogee Therapeutics logo

APGE — Apogee Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapMomentum Trap

Brief: Apogee Therapeutics Inc $681.4 Million Cash, Cash Equivalents And Marketable Securities Supports Runway Into Q1 2028

May 12 (Reuters) - Apogee Therapeutics Inc APGE.O:

APOGEE THERAPEUTICS INC: $681.4 MILLION CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES SUPPORTS RUNWAY INTO Q1 2028

Source text: ID:nGNXb0Hv2G

Further company coverage: APGE.O

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Apogee Therapeutics

See all news